Bioarctic Ab Stock Analysis
| BRCTF Stock | 33.14 2.15 6.09% |
BioArctic's financial leverage is the degree to which the firm utilizes its fixed-income securities and uses equity to finance projects. Companies with high leverage are usually considered to be at financial risk. BioArctic's financial risk is the risk to BioArctic stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Given that BioArctic's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which BioArctic is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of BioArctic to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, BioArctic is said to be less leveraged. If creditors hold a majority of BioArctic's assets, the Company is said to be highly leveraged.
BioArctic AB is overvalued with Real Value of 30.65 and Hype Value of 33.14. The main objective of BioArctic pink sheet analysis is to determine its intrinsic value, which is an estimate of what BioArctic AB is worth, separate from its market price. There are two main types of BioArctic's stock analysis: fundamental analysis and technical analysis.
The BioArctic pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and BioArctic's ongoing operational relationships across important fundamental and technical indicators.
BioArctic |
BioArctic Pink Sheet Analysis Notes
About 48.0% of the company shares are held by company insiders. The company had not issued any dividends in recent years. The quote for BioArctic AB is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on BioArctic AB please contact the company at 46 86 95 69 30 or go to https://www.bioarctic.se.BioArctic AB Investment Alerts
| BioArctic AB has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 23.15 M. Net Loss for the year was (119.79 M) with profit before overhead, payroll, taxes, and interest of 155.53 M. | |
| BioArctic generates negative cash flow from operations | |
| About 48.0% of the company shares are held by company insiders |
BioArctic Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.45 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioArctic's market, we take the total number of its shares issued and multiply it by BioArctic's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.BioArctic Profitablity
The company has Profit Margin (PM) of (0.05) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.Technical Drivers
As of the 14th of February 2026, BioArctic shows the Risk Adjusted Performance of 0.103, mean deviation of 0.5026, and Standard Deviation of 1.26. BioArctic AB technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BioArctic AB variance and potential upside to decide if BioArctic AB is priced correctly, providing market reflects its regular price of 33.14 per share. Given that BioArctic has total risk alpha of 0.0515, we suggest you to validate BioArctic AB's prevailing market performance to make sure the company can sustain itself at a future point.BioArctic AB Price Movement Analysis
Study |
The minimum time period for execution of this function requires larger time horizon. Please increase the time horizon for this function. The output start index for this execution was zero with a total number of output elements of zero. The Instantaneous Trendline is a moving-average-like indicator which is formed by removing the Dominant Cycle from BioArctic AB price series.
BioArctic Predictive Daily Indicators
BioArctic intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BioArctic pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 33.14 | |||
| Day Typical Price | 33.14 | |||
| Price Action Indicator | (1.07) | |||
| Period Momentum Indicator | (2.15) |
BioArctic Forecast Models
BioArctic's time-series forecasting models are one of many BioArctic's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BioArctic's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.BioArctic Assets Financed by Debt
Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the BioArctic's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of BioArctic, which in turn will lower the firm's financial flexibility.Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding BioArctic to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Global Correlations Now
Global CorrelationsFind global opportunities by holding instruments from different markets |
| All Next | Launch Module |
Complementary Tools for BioArctic Pink Sheet analysis
When running BioArctic's price analysis, check to measure BioArctic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioArctic is operating at the current time. Most of BioArctic's value examination focuses on studying past and present price action to predict the probability of BioArctic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioArctic's price. Additionally, you may evaluate how the addition of BioArctic to your portfolios can decrease your overall portfolio volatility.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |